Page last updated: 2024-08-26

bosentan anhydrous and Ventricular Dysfunction

bosentan anhydrous has been researched along with Ventricular Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duffy, JY; Lombardi, JP; Nelson, DP; Pearl, JM; Wagner, CJ	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Ventricular Dysfunction

Article	Year
Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation. The Annals of thoracic surgery, 2001, Volume: 72, Issue:2 Topics: Animals; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Infusions, Intravenous; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Receptors, Endothelin; RNA, Messenger; Sulfonamides; Swine; Ventricular Dysfunction	2001

Article

Year

Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation.

The Annals of thoracic surgery, 2001, Volume: 72, Issue:2

Topics: Animals; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Infusions, Intravenous; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Receptors, Endothelin; RNA, Messenger; Sulfonamides; Swine; Ventricular Dysfunction

2001